NCT03050164 - Bioequivalence Study of Gefitinib Tablets Under Fasting Conditions | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 8, 2016

Primary Completion Date

November 4, 2016

Study Completion Date

November 4, 2016

Conditions

Bioequivalence Study

Interventions

DRUG

Gefitinib Tablet 250mg of Hunan Kelun

Single dose of Gefitinib Tablet 250mg of Hunan Kelun was administered after a 10-hour overnight fast.

DRUG

Iressa® Tablet 250mg of AZN

Single dose of Iressa® Tablet 250mg of AZN was administered after a 10-hour overnight fast.